Pathogenesis and Host Response in Syrian Hamsters following Intranasal Infection with Andes Virus
Hantavirus pulmonary syndrome (HPS), also referred to as hantavirus cardiopulmonary syndrome (HCPS), is a rare but frequently fatal disease caused by New World hantaviruses. In humans HPS is associated with severe pulmonary edema and cardiogenic shock; however, the pathogenesis of this disease remains unclear largely due to a lack of suitable animal models for the study of disease progression. In this study we monitored clinical, virological, pathophysiological parameters and host immunological responses to decipher pathological factors and events in the lethal Syrian hamster model of HPS following intranasal inoculation of Andes virus. Transcriptional profiling of the host gene responses demonstrated a suppression of innate immune responses in most organs analyzed during the early stage of infection, except for in the lung which had low level activation of several pro-inflammatory genes. During this phase Andes virus established a systemic infection in hamsters, with viral antigen readily detectable in the endothelium of the majority of tissues analyzed by 7–8 days post-inoculation. Despite wide-spread infection, histological analysis confirmed pathological abnormalities were almost exclusively found in the lungs. Immediately preceding clinical signs of disease, intense activation of pro-inflammatory and Th1/Th2 responses were observed in the lungs as well as the heart, but not in peripheral organs, suggesting that localized immune-modulations by infection is paramount to pathogenesis. Throughout the course of infection a strong suppression of regulatory T-cell responses was noted and is hypothesized to be the basis of the aberrant immune activations. The unique and comprehensive monitoring of host immune responses to hantavirus infection increases our understanding of the immuno-pathogenesis of HPS and will facilitate the development of treatment strategies targeting deleterious host immunological responses.
Vyšlo v časopise:
Pathogenesis and Host Response in Syrian Hamsters following Intranasal Infection with Andes Virus. PLoS Pathog 7(12): e32767. doi:10.1371/journal.ppat.1002426
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002426
Souhrn
Hantavirus pulmonary syndrome (HPS), also referred to as hantavirus cardiopulmonary syndrome (HCPS), is a rare but frequently fatal disease caused by New World hantaviruses. In humans HPS is associated with severe pulmonary edema and cardiogenic shock; however, the pathogenesis of this disease remains unclear largely due to a lack of suitable animal models for the study of disease progression. In this study we monitored clinical, virological, pathophysiological parameters and host immunological responses to decipher pathological factors and events in the lethal Syrian hamster model of HPS following intranasal inoculation of Andes virus. Transcriptional profiling of the host gene responses demonstrated a suppression of innate immune responses in most organs analyzed during the early stage of infection, except for in the lung which had low level activation of several pro-inflammatory genes. During this phase Andes virus established a systemic infection in hamsters, with viral antigen readily detectable in the endothelium of the majority of tissues analyzed by 7–8 days post-inoculation. Despite wide-spread infection, histological analysis confirmed pathological abnormalities were almost exclusively found in the lungs. Immediately preceding clinical signs of disease, intense activation of pro-inflammatory and Th1/Th2 responses were observed in the lungs as well as the heart, but not in peripheral organs, suggesting that localized immune-modulations by infection is paramount to pathogenesis. Throughout the course of infection a strong suppression of regulatory T-cell responses was noted and is hypothesized to be the basis of the aberrant immune activations. The unique and comprehensive monitoring of host immune responses to hantavirus infection increases our understanding of the immuno-pathogenesis of HPS and will facilitate the development of treatment strategies targeting deleterious host immunological responses.
Zdroje
1. SchmaljohnCNicholST 2007 Bunyaviridae. KnipeDMHowleyPA Field's virology 5th ed Philadelphia Lippincott-Williams & Wilkins 1742 1789
2. NicholSTElliottRMGoldbachRPlyusninASchmaljohnCS 2005 Bunyaviridae. FauquetCMMayoMAManiloffJDesselbergerUBallLA Virus Taxonomy, VIIIth Report of the International Committee on Taxonomy of Viruses London Elsevier Academic Press 695 716
3. JonssonCBFigueiredoLTMVapalahtiO 2010 A global perspective on hantavirus ecology, epidemiology and disease. Clin Microbiol Rev 23 412 441
4. KhanASYoungJC 2001 Hantavirus pulmonary syndrome: at the cross roads. Curr Opin Infect Dis 14 205 209
5. CDC 2010 Hantavirus pulmonary syndrome (Hantavirus disease) (HPS) 2010 case definition. Available: http://www.cdc.gov/ncphi/disss/nndss/casedef/hantaviruscurrent.htm. Accessed 2 July 2010
6. EnriaDABriggilerAMPiniNLevisS 2001 Clinical manifestations of New World hantaviruses. Curr Top Microbiol Immunol 256 117 134
7. GeimonenENeffSRaymondTKocerSSGavrilovskaya 2002 Pathogenic and non-pathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A 99 13837 13842
8. LevineJRPrescottJBrownKSBestSMEbiharaH 2010 Antagonism of type I interferon responses by New World hantaviruses. J Virol 84 11790 11801
9. AlffPJGavrilovskayaINGorbunovaEEndrissKChongY 2006 The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 80 9676 9686
10. SpiropoulouCFAlbarinoCGKsiazekTGRollinPE 2007 Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signalling. J Virol 81 2769 2776
11. BorgesAACamposGMMoreliMLSouzaRLMSaggioroFP 2008 Role of Th1 and Th2 cytokines on pathogenesis and prognosis of hantavirus cardiopulmonary syndrome. Microbe Infect 10 1150 1157
12. MoriMRothmanALKuraneIMontoyaJMNolteKB 1999 High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 179 295 302
13. KilpatrickEDTerajimaMKosterFTCatalinaMDCruzJ 2004 Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 172 3297 3304
14. GroenJGerdingMKoemanJPRohollPJvan AmerongenG 1995 A macaque model for hantavirus infection. J Infect Dis 172 38 44
15. KlingstromJPlyusninAVaheriALundkvistA 2002 Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J Virol 76 444 449
16. SironenTKlingstromJVaheriAAnderssonLCLundkvistA 2008 Pathology of Puumala hantavirus infection in macaques. PLoS One 3 e3035
17. HooperJWLarsenTCusterDMSchmaljohnCS 2001 A lethal disease model for hantavirus pulmonary syndrome. Virology 289 6 14
18. CampenMJMilazzoMLFulhorstCFObot AkataCJKosterF 2006 Characterization of shock in a hamster model of hantavirus infection. Virology 356 45 49
19. Wahl-JensenVChapmanJAsherLFisherRZimmermanM 2007 Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters. J Virol 81 7449 7462
20. MilazzoMLEyzaguirreEJMolinaCPFulhorstC 2002 Maporal viral infection in the Syrian golden hamsters: a model of hantavirus pulmonary syndrome. J Infect Dis 186 1390 1395
21. EyzaguirreEJMilazzoMLKosterFTFulhortsC 2008 Choclo virus infection in the Syrian golden hamster. Am J Trop Med Hyg 78 669 674
22. SafronetzDHegdeNREbiharaHDentonMKobingerGP 2009 Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with Andes virus. J Virol 83 7285 7295
23. ZivcecMSafronetzDHaddockEFeldmannHEbiharaH 2011 Validation of assays to monitor immune responses in Syrian hamsters (Mesocricetus auratus). J Immunol Method 368 24 35
24. GowenBBJulanderJGLondonNRWongM-HLarsonD 2010 Assessing changes in vacular permeability in a hamster model of viral hemorrhagic fever. Virology J 7 240
25. ZakiSRGreerPWCoffieldLMGoldsmithCSNolteKB 1995 Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 146 552 579
26. ToroJVegaJDKhanASMillsJNPadulaP 1998 An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis 4 687 694
27. RoweRKPekoszA 2006 Bidirectional secreation and nonciliated cell tropism following andes virus infection of primary airway epithelial cell cultures. J Virol 80 1087 1097
28. PadulaPJEdelsteinAMiquelSDLopezNMRossiCM 1998 Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virol 241 323 330
29. MartinezVPBellomoCSan JuanJPinnaDForlenzaR 2005 Person-to-person transmission of Andes virus. Emerg Infect Dis 11 1848 1853
30. CastilloCNaranjoJSeoulvedaAOssaGLevyH 2001 Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest 120 548 554
31. Shrivastava-RanjanPRollinPSpiropoulouCF 2010 Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-Cadherin. J Virol 84 11227 11234
32. RouseBTHorohovDW 1986 Immunosuppression in viral infections. Rev Infect Dis 8 850 873
33. TortorellaDGewurzBEFurmanMHSchistDJPloeghHL 2000 Viral subversion of the immune system. Annu Rev Immunol 18 861 926
34. StoltzMAhlmCLundkvistAKlingstromJ 2007 Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-gamma-induced nitric oxide production. J Virol 81 8685 8691
35. RobertsonSJHasenkrugKJ 2006 The role of virus-induced regulatory T cells in immunopathology. Springer Semin Immunopathol 28 51 62
36. RouseBTSuvasS 2004 Regulatory cells and infectious agents: detentes cordiale and contraire. J Immunol 173 2211 2215
37. SchountzTPrescottJCogswellACOkoLMirowsky-GarciaK 2007 Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc Natl Acad Sci U S A 104 15496 15501
38. EasterbrookJDZinkMCKleinSL 2007 Regulatory T cells enhance persistence of the zoonotic pathogen Seoul virus in its reservoir host. Proc Natl Acad Sci U S A 104 15502 15507
39. EasterbrookJDKleinSL 2008 Immunological mechanisms mediating hantavirus persistence in rodent reservoirs. PLoS Pathog 4 e1000172
40. ZhuLYChiLJWangXZhouH 2009 Reduced circulating CD4+CD25+ cell populations in haemorrhagic fever with renal syndrome. Clin Exp Immunol 156 88 96
41. SaggioroFPRossiMADuarteMISMartinCCSAlvesVAF 2007 Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J Infect Dis 195 1541 1549
42. KhaiboullinaSFNetskiDMKrumpePSt JoerSC 2000 Effects of tumor necrosis factor alpha on sin nombre virus infection in vitro. J Virol 74 11966 11971
43. MackowERGavrilovskayaIN 2009 Hantavirus regulation of endothelial cell functions. Thromb Haemost 102 1030 1041
44. JanssenSPGayan-RamirezGVan den BerghAHerijgersPMaesK 2005 Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111 996 1005
45. HedayatMMahmoudiMJRoseNRRezaeiN 2010 Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 15 543 562
46. AfanayevaMWangYKayaZStaffordEADohmenKM 2001 Interleukin-12 receptor /STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation 104 3145 3151
47. HarringtonLEHattonRDManganPRTurnerHMurphyTL 2005 Interleukin 17-producing CD4+ effector cells develop via a lineage distinct from T helper type 1 and 2 lineages. Nat Immunol 6 1123 1132
48. TesmerLALundySKSarkarSFoxDA 2008 Th17 cells in human disease. Immunol Rev 223 87 113
49. ChengXYuXDingYJFuQQXieJJ 2008 Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 127 89 97
50. TangTTDingYJLiaoYHYuXXiaoH 2010 Defective circulating CD4+CD25+Foxp3+CD127low regulatory T-cells in patients with chronic heart failure. Cell Physiol Biochem 25 451 458
51. HammerbeckCDHooperJW 2011 T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome. J Virol 85 9929 9944
52. TerajimaMEnnisFA 2011 T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome. Viruses 3 1059 1073
53. SundstromJBMcMullanLKSpiropoulouCFHooperWCAnsariAA 2001 Hanyavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol 75 6070 6085
54. MeissnerJDRoweJEBoruckiMKJoer SCSt 2002 Complete nucleotide sequence of a Chilean hantavirus. Virus Res 89 131 143
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 12
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Controlling Viral Immuno-Inflammatory Lesions by Modulating Aryl Hydrocarbon Receptor Signaling
- Fungal Virulence and Development Is Regulated by Alternative Pre-mRNA 3′End Processing in
- Epstein-Barr Virus Nuclear Antigen 3C Stabilizes Gemin3 to Block p53-mediated Apoptosis
- Engineered Immunity to Infection